Average Co-Inventor Count = 5.49
ph-index = 21
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (70 from 666 patents)
2. Incyte Holdings Corporation (27 from 147 patents)
3. Bristol-myers Squibb Compnay (1 from 3,685 patents)
4. Incyte Incorporation (1 from 4 patents)
72 patents:
1. 12466822 - Heterocyclic compounds as immunomodulators
2. 12441727 - Tricyclic compounds as inhibitors of KRAS
3. 12415809 - Pyrrolotriazine compounds as tam inhibitors
4. 12201636 - Heterocyclylamines as PI3K inhibitors
5. 12084449 - Imidazotriazines and imidazopyrimidines as kinase inhibitors
6. 12084430 - Tricyclic urea compounds as JAK2 V617F inhibitors
7. 12030889 - Imidazopyridazine and imidazopyridine compounds and uses thereof
8. 11840534 - Substituted tricyclic compounds as FGFR inhibitors
9. 11673894 - Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors
10. 11591338 - Pyrrolotriazine compounds as TAM inhibitors
11. 11530214 - Bicyclic heterocycles as FGFR inhibitors
12. 11459329 - Imidazopyridazine and imidazopyridine compounds and uses thereof
13. 11433071 - Heterocyclylamines as PI3K inhibitors
14. 11401272 - Heterocyclic compounds as LSD1 inhibitors
15. 11261191 - Imidazotriaines and imidazopyrimidines as kinase inhibitors